Anna Truppel

Anna Truppel has extensive experience in the pharmaceutical industry, with a focus on clinical development and medical affairs. Anna currently holds the position of Senior Vice President of Clinical Development at 2seventy bio, where they have been since 2021. Prior to this role, they served as the VP of Oncology Clinical Development at the same company, from November 2021 to February 2023. Before joining 2seventy bio, Anna worked at bluebird bio as the VP of Clinical Development and Medical Affairs Oncology from April 2019 to November 2021. From 2015 to 2021, they held the role of Head of Patient Engagement at Roche. Anna also has experience at F. Hoffmann La Roche Ltd., where they served as the Group International Medical Director Hematology from April 2014 to November 2015, the Senior International Medical Leader Hematology from January 2013 to March 2014, and the International Medical Leader Hematology from February 2011 to December 2012. Prior to joining F. Hoffmann La Roche Ltd., Anna worked at Roche Pharma Schweiz, starting as the Medical Manager for Osteoporosis from January 2007 to August 2009, and then transitioning to the role of Medical Manager for Hematology from September 2009 to January 2011.

Anna Truppel attended the University of Zurich from 2000 to 2006, where they earned a Doctor of Medicine (M.D.) degree in Medizin. In 2004 and 2005, they also studied at the University of Vienna, although the specific degree and field of study were not provided.